title: Severe imatinib-associated muscle edema in patients with chronic myelogenous leukemia and marked leukocytosis.
authors.forename: Sivamurthy
authors.initials: S
authors.lastname: Kyathari
authors.forename: Kuo
authors.initials: K
authors.lastname: Chao
authors.forename: Delong
authors.initials: D
authors.lastname: Liu
authors.forename: Karen
authors.initials: K
authors.lastname: Seiter
mesh_terms: D000328:Adult; D001549:Benzamides; D004487:Edema / Q000139:chemically induced; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy*; D007964:Leukocytosis / Q000139:chemically induced; D008279:Magnetic Resonance Imaging; D018482:Muscle, Skeletal / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate